Search
MiMedx Group Inc
MDXGAdd to Watchlist
4.130USD
-0.140-3.28%
Close 07-31 16:00（ET）Quotes delayed by 15 min
601.99MMarket Cap
19.87P/E TTM
More Details of MiMedx Group Inc Company
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
MiMedx Group Inc Info
Ticker SymbolMDXG
Company nameMiMedx Group Inc
IPO dateAug 20, 2007
CEOCapper (Joseph H)
Number of employees837
Security typeOrdinary Share
Fiscal year-endAug 20
Address1775 W Oak Commons Court, Ne
CityMARIETTA
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code30062
Phone17706519100
Websitehttps://mimedx.com/
Ticker SymbolMDXG
IPO dateAug 20, 2007
CEOCapper (Joseph H)
Company Executives of MiMedx Group Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
73.33K
-27.03%
Mr. William Frank (Butch) Hulse, IV
Mr. William Frank (Butch) Hulse, IV
Chief Administrative Officer, General Counsel
Chief Administrative Officer, General Counsel
--
--
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Dr. M. Kathleen Behrens Wilsey, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. K. Todd Newton
Mr. K. Todd Newton
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Chief Executive Officer, Director
Chief Executive Officer, Director
310.29K
-190.25%
Ms. Ricci S. Whitlow
Ms. Ricci S. Whitlow
Executive Vice President, Chief Operating Officer
Executive Vice President, Chief Operating Officer
284.25K
+28.78%
Mr. James L. Bierman
Mr. James L. Bierman
Independent Director
Independent Director
263.68K
+19.31%
Dr. Cato T. Laurencin, M.D., Ph.D.
Dr. Cato T. Laurencin, M.D., Ph.D.
Independent Director
Independent Director
181.92K
--
Ms. Dorothy E. Puhy
Ms. Dorothy E. Puhy
Independent Director
Independent Director
108.51K
+46.92%
Ms. Kimberly (Kim) Maersk-Moller
Ms. Kimberly (Kim) Maersk-Moller
Chief Commercial Officer
Chief Commercial Officer
73.33K
-27.03%
FAQs
Who are the top five shareholders of MiMedx Group Inc?
The top five shareholders of MiMedx Group Inc are: Mr. Joseph H. (Joe) Capper
How many institutions hold shares of MiMedx Group Inc (MDXG)?
As of 2026Q1, 462 institutions hold shares of MiMedx Group Inc, with a combined market value of approximately 116.77M, accounting for 78.40% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 6172968.00.
What is the biggest source of revenue for MiMedx Group Inc?
In 2026Q1, the Advanced Wound Care business generated the highest revenue for MiMedx Group Inc, amounting to 276.33M and accounting for 66.01% of total revenue.